沃丽汀治疗中心性浆液性脉络膜视网膜病变的疗效分析  

The efficacy of Joletin（100） Tablets as the treatment for central serouschoroiretinopathy

作　　者：郭梦翔[1] 易长贤[1] 

机构地区：[1]中山大学中山眼科中心,广州510060

出　　处：《中国实用眼科杂志》2007年第12期1356-1357,共2页Chinese Journal of Practical Ophthalmology

摘　　要：目的观察沃丽汀片剂治疗中心性浆液性脉络膜视网膜病变的临床疗效。方法前瞻性分析60例60眼中浆患者的临床资料,治疗组30例患者接受沃丽汀片剂口服,300μg/d,分3次口服,共30天。对照组30例患者接受常规药物治疗。服药后7、14、30、60天复诊,观察视力、裂隙灯检查、视野、FFA和OCT。结果治疗组的总有效率为86.7%,13.3%的患者无效。对照组的总有效率为60%。结论沃丽汀可以促进中浆的视网膜下液体的吸收。Objective To investigate the clinic efficacy of Joletion Tablets as the treatment for cena＇al serous choroiretinopathy. Methodes Prospectively analysis the clinical documents of 60 cases（60 eyes）with central serous choroiretinopathy. 30 cases accept Joletin Tablets 300μg/d,tid,totally for 30 days, the other cases receive regular medicine. Each case was followed up with visual acuity,slit-lamp microscope examination, visual field,fundus fluoresceins angiography （FFA）and optical coherent topography（OCT）7,14,30 and 60 days after the therapy. Result The total effective rate of the treatment group was 86.7% and only 13.3% cases showed no effect. While the total effective rate of the control group was 60%. Conclusion Joletin is effective for the absorption of subretinal liquid in patients with central serous choroiretinapthy.

关 键 词：沃丽汀 中心性浆液性脉络膜视网膜病变 疗效 病例 

分 类 号：R774.1[医药卫生—眼科]